Created in 1972, BELLCO is among the European leaders in the development and sales of Renal Care medical devices.

Operating from its production sites in Mirandola (Italy) and Forquevaux (France) through a worldwide sales network, and active in all fields of kidney diseases, Bellco focuses on advanced therapies (HDF[HemoDiaFiltration], HF [HemoFiltration], CPFA [Coupled Plasma Filtration Adsorption], CRRT [Continuous Renal Replacement Therapies]) and relies on a strong relationship with European top nephrologists.

The goal of the transaction is to complete the complex carve-out from the listed Sorin group, and to stay focused on renal care, and in particular to give the group all the necessary support to grow and to become a key player in highly innovative therapies and machines.